摘要 Objective: Calcium oxalate crystals are found in majority of kidney stones with calcium oxalate monohydrate (COM) as one of the primary types of kidney stones. Various methods of treatment exist, including herbal treatment in the Philippines that uses the medicinal herb Blumea balsamifera (B. balsamifera). Methods: The effect of B. balsamifera extract on the morphology of calcium oxalate crystals was studied by light microscopy, image analysis, powder X-ray diffraction and scanning electron microscopy. Results: The extract decreased the crystal size by 5.22%-82.62% depending on the degree of supersaturation. Through analysis of the projected area of the crystals, the extract was found to shift the phase of the crystals from COM to calcium oxalate dihydrate (COD). This shift in phase is significant with a COM to COD shift of 88.26% at 0.5 mg/mL of extract and 91.53% at 1.0 mg/mL of extract. Scanning election microscopic (SEM) images revealed aggregation of crystals at 0 mg/mL of extract. At 1.0 mg/mL of extract, the scanning electron micrographs showed discernible crystal unit boundaries. Conclusion:B. balsamifera extract was observed to have decreased crystal size, shifted crystal phase from COM to COD and prevented the aggregation of calcium oxalate crystals.
Abstract: Objective: Calcium oxalate crystals are found in majority of kidney stones with calcium oxalate monohydrate (COM) as one of the primary types of kidney stones. Various methods of treatment exist, including herbal treatment in the Philippines that uses the medicinal herb Blumea balsamifera (B. balsamifera). Methods: The effect of B. balsamifera extract on the morphology of calcium oxalate crystals was studied by light microscopy, image analysis, powder X-ray diffraction and scanning electron microscopy. Results: The extract decreased the crystal size by 5.22%-82.62% depending on the degree of supersaturation. Through analysis of the projected area of the crystals, the extract was found to shift the phase of the crystals from COM to calcium oxalate dihydrate (COD). This shift in phase is significant with a COM to COD shift of 88.26% at 0.5 mg/mL of extract and 91.53% at 1.0 mg/mL of extract. Scanning election microscopic (SEM) images revealed aggregation of crystals at 0 mg/mL of extract. At 1.0 mg/mL of extract, the scanning electron micrographs showed discernible crystal unit boundaries. Conclusion:B. balsamifera extract was observed to have decreased crystal size, shifted crystal phase from COM to COD and prevented the aggregation of calcium oxalate crystals.
通讯作者:
Charlimagne M. Montealegre,E-mail address:charlimagne.montealegre@coe.upd.edu.ph
E-mail: charlimagne.montealegre@coe.upd.edu.ph
引用本文:
Charlimagne M. Montealegre, Rizalinda L. De Leon. Effect of Blumea balsamifera extract on the phase and morphology of calcium oxalate crystals[J]. Asian Journal of Urology, 2017, 4(4): 201-207.
Charlimagne M. Montealegre, Rizalinda L. De Leon. Effect of Blumea balsamifera extract on the phase and morphology of calcium oxalate crystals. Asian Journal of Urology, 2017, 4(4): 201-207.
Kirejczyk JK, Porowski T, Filonowicz R, Kazberuk A, Stefanowicz M, Wasilewska A, et al. An association between kidney stone composition and urinary metabolic disturbances in children. J Pediatr Urol 2014;10:130-5.
[2]
Canales BK, Anderson L, Higgins L, Ensrud-Bowlin K, Roberts KP, Wu B, et al. Proteome of human calcium kidney stones. Urology 2010;76:1017.e13-20.
[3]
Siddiqui AA, Mushtaq S. Urolithiasis. London:Springer London; 2012.
[4]
Hughes P. The CARI guidelines. Kidney stones epidemiology. Nephrol Carlt 2007;12(Suppl 1):S26-30.
[5]
Abdel-Aal EA, Daosukho S, El-Shall H. Effect of supersaturation ratio and Khella extract on nucleation and morphology of kidney stones. J Cryst Growth 2009;311:2673-81.
[6]
Farmanesh S, Chung J, Chandra D, Sosa RD, Karande P, Rimer JD. High-throughput platform for design and screening of peptides as inhibitors of calcium oxalate monohydrate crystallization. J Cryst Growth 2013;373:13-9.
[7]
Farmanesh S, Ramamoorthy S, Chung J, Asplin JR, Karande P, Rimer JD. Specificity of growth inhibitors and their cooperative effects in calcium oxalate monohydrate crystallization. J Am Chem Soc 2014;136:367-76.
[8]
Jung T, Kim WS, Choi CK. Biomineralization of calcium oxalate for controlling crystal structure and morphology. Mater Sci Eng C 2004;24:31-3.
[9]
Goiko M, Dierolf J, Gleberzon JS, Liao Y, Grohe B, Goldberg HA, et al. Peptides of Matrix Gla protein inhibit nucleation and growth of hydroxyapatite and calcium oxalate monohydrate crystals. PLoS One 2013;8:e80344.
[10]
Grases F, Prieto RM, Gomila I, Sanchis P, Costa-Bauzá A. Phytotherapy and renal stones:the role of antioxidants. A pilot study in Wistar rats. Urol Res 2009;37:35-40.
[11]
Gangu KK, Tammineni GR, Dadhich AS, Mukkamala SB. Control of phase and morphology of calcium oxalate crystals by natural polysaccharide. Gum Arab Mol Cryst Liq Cryst 2014;591:114-22.
[12]
Saha S, Verma RJ. Inhibition of calcium oxalate crystallisation in vitro by an extract of Bergenia ciliata. Arab J Urol 2013;11:187-92.
[13]
History of kidney stones e kidney Stoners.org. 2014. http://www.kidneystoners.org/information/history-of-stones/[accessed 07.11.14].
[14]
Alok S, Jain SK, Verma A, Kumar M, Sabharwal M. Pathophysiology of kidney, gallbladder and urinary stones treatment with herbal and allopathic medicine:a review. Asian Pac J Trop Dis 2013;3:496-504.
[15]
Rodgers AL, Allie-Hamdulay S, Jackson GE, Durbach I. Theoretical modeling of the urinary supersaturation of calcium salts in healthy individuals and kidney stone patients:precursors, speciation and therapeutic protocols for decreasing its value. J Cryst Growth 2013;382:67-74.
[16]
Jung T, Kim WS, Kyun Choi C. Crystal structure and morphology control of calcium oxalate using biopolymeric additives in crystallization. J Cryst Growth 2005;279:154-62.
[17]
Akyol E, Öner M. Controlling of morphology and polymorph of calcium oxalate crystals by using polyelectrolytes. J Cryst Growth 2014;401:260-5.
[18]
King H, Ferguson S. An X-ray diffraction study of PMNePT ceramics near the morphotropic phase boundary. Proc Int Conf Sonar Sens Syst 2002;2.
Christopher Hartman, Nikhil Gupta, David Leavitt, David Hoenig, Zeph Okeke, Arthur Smith. Advances in percutaneous stone surgery[J]. Asian Journal of Urology, 2015, 2(1): 26
-32
.
